Dow Down 0.36% Nasdaq Down 0.53%

Novo Nordisk A/S (NVO)

-NYSE
47.54 0.76(1.62%) Sep 12, 4:01PM EDT
Prev Close:46.78
Open:47.62
Bid:47.62 x 8100
Ask:49.01 x 8100
1y Target Est:49.37
Beta:1.04
Next Earnings Date:N/A
Day's Range:47.37 - 47.72
52wk Range:32.55 - 48.42
Volume:1,569,410
Avg Vol (3m):913,008
Market Cap:124.98B
P/E (ttm):27.35
EPS (ttm):1.74
Div & Yield:0.61 (1.30%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVOUp 1.62%124.98B
LLY69.95B
PFE186.61B
SNY148.08B

Key Statistics

Forward P/E (1 yr):23.77
P/S (ttm):8.42
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.78
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback